Markets
Security ▼ | Price | % | Buy | Sell | Target price | Potential |
---|---|---|---|---|---|---|
Provectus Ph |
-
- |
- | 0 | 0 | - | - |
Proteome Sciences |
€0.040
26.04.24 |
- | 0 | 0 | - | - |
Protara Therapeutics Inc. |
€2.74
26.04.24 |
2.820% | 0 | 0 | - | - |
Progen Pharmaceuticals Ltd |
€0.12
16.03.20 |
954.550% | 0 | 0 | - | - |
Prescient Therapeutics Ltd. |
€0.11
18.08.21 |
-5.170% | 0 | 0 | - | - |
Presbia plc |
€0.055
01.10.19 |
- | 0 | 0 | - | - |
Premier Diversified Holdings Inc |
€0.004
18.08.21 |
14.290% | 0 | 0 | - | - |
Precipio Inc |
€0.25
20.11.23 |
2.740% | 0 | 0 | - | - |
Prana Biotechnology Ltd. |
€0.002
26.04.24 |
- | 0 | 0 | - | - |
Port Erin Biopharma Investments Ltd |
€0.085
26.04.24 |
1.190% | 0 | 0 | - | - |
Plant Advanced T. |
€9.95
26.04.24 |
-1.490% | 0 | 0 | - | - |
Pixium Vision S.A. |
€0.019
20.09.23 |
-8.610% | 0 | 0 | - | - |
Phylogica Ltd. |
€0.089
18.08.21 |
- | 0 | 0 | - | - |
Pharnext S.A. |
€0.000
15.09.23 |
- | 1 | 0 | €0.000 | -100.000% |
PharmAust Ltd. |
€0.14
26.04.24 |
-3.520% | 1 | 0 | - | - |
Pernix Therapeutics Hldgs |
-
- |
- | 0 | 0 | - | - |
PDS Biotechnology Corp. |
€3.06
26.04.24 |
-1.450% | 1 | 0 | - | - |
PAVmed Inc |
€0.20
06.12.23 |
-12.070% | 0 | 0 | - | - |
Palatin Technologies Inc. |
€1.70
26.04.24 |
3.140% | 0 | 4 | - | - |
Oxford BioMedica PLC |
€2.52
26.04.24 |
4.130% | 0 | 0 | - | - |
Ose Pharma International S.A. |
€5.62
25.04.24 |
-1.240% | 0 | 1 | - | - |
Orexigen Therapeutics Inc. |
-
- |
- | 0 | 0 | - | - |
Oragenics Inc. |
€7.60
09.02.24 |
- | 1 | 34 | €8.00 | 5.319% |
Oncotherapy Science Inc. |
€0.085
26.04.24 |
-6.590% | 0 | 0 | - | - |
Oncopeptides AB |
€0.25
26.04.24 |
5.240% | 1 | 0 | €1.00 | 296.040% |
Onconova Therapeutics Inc |
€0.59
26.04.24 |
-1.690% | 1 | 0 | €3.00 | 408.475% |
Oncolys Biopharma Inc. |
€9.20
18.08.21 |
2.790% | 0 | 0 | - | - |
Omega Diagnostics Group plc |
€0.043
26.04.24 |
-2.300% | 0 | 0 | - | - |
Nuvo Pharmaceuticals Inc. |
€0.90
16.03.23 |
-1.640% | 0 | 0 | - | - |
Nuvectra Corp |
€0.10
13.12.19 |
-23.080% | 0 | 0 | - | - |